JPMORGAN CHASE & CO

Holdings History for Cartesian Therapeutics, Inc. - Common Stock (RNAC)

Symbol: RNAC on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Shares Owned: 1,675,636 shares
Security Ownership %: 6.1%

Shares, Excluding Options vs Price

Value, Excluding Options

JPMORGAN CHASE & CO. ownership in Cartesian Therapeutics, Inc. Common Stock (RNAC)

25 Apr 2025 - JPMORGAN CHASE & CO. has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,675,636 shares of Cartesian Therapeutics, Inc. Common Stock (RNAC). This represents 6.1% ownership of the company. This is the first filing by JPMORGAN CHASE & CO disclosing ownership of Cartesian Therapeutics, Inc. Common Stock (RNAC).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
JPMORGAN CHASE & CO.	6.1%		$20,459,516	1,675,636			$12.21	13G	31 Mar 2025	25 Apr 2025, 14:57

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	0%	$42,460	5,889	-235	-3.8%	$7.21	Q4 2025
30 Sep 2025	0%	0%	$62,588	6,124	+44	+0.72%	$10.22	Q3 2025
30 Jun 2025	0%	-0%	$63,171	6,080	-188,957	-97%	$10.39	Q2 2025
31 Mar 2025	0%	-0%	$2,570,588	195,037	-79,703		$13.18	Q1 2025
31 Dec 2024	0%	-0%	$4,920,593	274,740	-34,278	-11%	$17.91	Q4 2024
30 Sep 2024	0%	+0%	$4,981,371	309,018	+2,688	+0.88%	$16.12	Q3 2024
30 Jun 2024	0%	+0%	$8,273,973	306,330	+306,330	NEW	$27.01	Q2 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.